For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The real deal on diabetes and CVD: Jackson presents surprising findings
+Print Archive
SOUTH GP CME
The real deal on diabetes and CVD: Jackson presents surprising findings
Wednesday 10 October 2018, 05:00 AM

People with diabetes are at higher risk than the general population of a cardiovascular event, but their risk will vary by individual
Virginia McMillan completes her coverage from the South GP CME held in Christchurch in August and attended by around 800 delegates and exhibitors
Large numbers of New Zealanders with type 2 diabetes are not at high risk of a cardiovascular event – and many are at surprisingly low risk, epidemi, Rod Jackson, Epidemiologist Rod Jackson has identified huge variation in CVD risk for people with diabetes
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.